Evidence map›Paper›PMID 32134970›Full record

ArticlePloS one2020

DMSO-mediated curing of several yeast prion variants involves Hsp104 expression and protein solubilization, and is decreased in several autophagy related gene (atg) mutants.

Jane E Dorweiler, Joanna O Obaoye, Mitch J Oddo, Francesca M Shilati, Grace M Scheidemantle, Thomas J Coleman, Jacob A Reilly, Gregory R Smith, Anita L Manogaran

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Yeast Prions: Discovery, Nature, Cellular Manipulation and Implication.Journal of microbiology and biotechnology · 2025
    Review
  2. Review
  3. Article
  4. Human proteins curing yeast prions.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Article
  6. Review
  7. Mechanisms for Curing Yeast Prions.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jane E DorweilerDepartment of Biological Sciences, Marquette University, Milwaukee, WI, United States of America.
Joanna O ObaoyeDepartment of Biological Sciences, Marquette University, Milwaukee, WI, United States of America.
Mitch J OddoDepartment of Biological Sciences, Marquette University, Milwaukee, WI, United States of America.
Francesca M ShilatiDepartment of Biological Sciences, Marquette University, Milwaukee, WI, United States of America.
Grace M ScheidemantleDepartment of Biological Sciences, Marquette University, Milwaukee, WI, United States of America.
Thomas J ColemanDepartment of Biology, Lakeland University, Plymouth, WI, United States of America.
Jacob A ReillyDepartment of Biological Sciences, Marquette University, Milwaukee, WI, United States of America.
Gregory R SmithDepartment of Biology, Lakeland University, Plymouth, WI, United States of America.
Anita L ManogaranDepartment of Biological Sciences, Marquette University, Milwaukee, WI, United States of America.ORCID 0000-0003-0844-1479
Marquette University · USLakeland College · US

Funding

Investigation of cellular factors involved in yeast prion appearanceR15GM109336 · NIGMS · MARQUETTE UNIVERSITY · PI MANOGARAN, ANITA L. · 2014 to 2014
$343k
NIGMS NIH HHS R15 GM109336
6 · The paper itself

Abstract

Chaperones and autophagy are components of the protein quality control system that contribute to the management of proteins that are misfolded and aggregated. Here, we use yeast prions, which are self-perpetuating aggregating proteins, as a means to understand how these protein quality control systems influence aggregate loss. Chaperones, such as Hsp104, fragment prion aggregates to generate more prion seeds for propagation. While much is known about the role of chaperones, little is known about how other quality control systems contribute to prion propagation. We show that the aprotic solvent dimethyl sulfoxide (DMSO) cures a range of [PSI+] prion variants, which are related to several misfolded aggregated conformations of the Sup35 protein. Our studies show that DMSO-mediated curing is quicker and more efficient than guanidine hydrochloride, a prion curing agent that inactivates the Hsp104 chaperone. Instead, DMSO appears to induce Hsp104 expression. Using the yTRAP system, a recently developed transcriptional reporting system for tracking protein solubility, we found that DMSO also rapidly induces the accumulation of soluble Sup35 protein, suggesting a potential link between Hsp104 expression and disassembly of Sup35 from the prion aggregate. However, DMSO-mediated curing appears to also be associated with other quality control systems. While the induction of autophagy alone does not lead to curing, we found that DMSO-mediated curing is dramatically impaired in autophagy related (atg) gene mutants, suggesting that other factors influence this DMSO mechanism of curing. Our data suggest that DMSO-mediated curing is not simply dependent upon Hsp104 overexpression alone, but may further depend upon other aspects of proteostasis.

Indexed as

Autophagy-Related ProteinsDimethyl SulfoxideHeat-Shock ProteinsMutationPeptide Termination FactorsPrionsProtein AggregatesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSolubilityUp-RegulationAutophagy-Related ProteinsDimethyl SulfoxideHeat-Shock ProteinsHsP104 protein, S cerevisiaePeptide Termination FactorsPrionsProtein AggregatesSaccharomyces cerevisiae ProteinsSUP35 protein, S cerevisiae

Identifiers

PMID32134970
PMCPMC7058316
OpenAlexW3010080111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.